💰 Financial Record
paymentTransaction Details
Amount
USD
$2,500,000,000.0
Payer (From)
Investors
Linked to local and regional investors
Payee (To)
Life Sciences Venture Capital
Linked to Life Sciences Venture Capital
Transaction Date
January 01, 2012
Description
Contracted fundraising amount ($2.5 billion).
Additional Details
Date string:
2012
Amount string:
2500000000
Source document:
HOUSE_OVERSIGHT_024016.jpg
📄 Source Document
HOUSE_OVERSIGHT_024016.jpg
ESTATE Collection
Document Summary
This document appears to be page 5 of a confidential investment memorandum for a fund named 'NLV-III' (likely New Leaf Ventures III). It outlines the investment thesis, citing a favorable regulatory environment due to increased FDA approvals and the FDASIA act of 2012, as well as favorable capital market dynamics caused by a contraction in venture capital fundraising which reduces competition for deals. The document bears a House Oversight Committee stamp, indicating it was part of a congressional investigation.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein financial record